To model early changes in ovarian cancer development, we generated iFTSEC283 and iOSE11 cells overexpressing a dominant-negative TP53 mutant (p.R175H) because p53 alterations are the earliest and most prevalent in HGSOC. This evidence concerns the gene TP53 and ovarian cancer.